Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF
João Pedro Ferreira, Job A.J. Verdonschot, Ping Wang, Anne Pizard, Timothy Collier, Fozia Ahmed, Hans‐Peter Brunner‐La Rocca, Andrew L. Clark, Franco Cosmi, Joe Cuthbert, Javier Dı́ez, Frank Edelmann, Nicolas Girerd, Arantxa González, Stéphanie Grojean, Mark R. Hazebroek, Muhammad Javed Khan, Roberto Latini, Mamas A. Mamas, Beatrice Mariottoni, Blerim Mujaj, Pierpaolo Pellicori, Johannes Petutschnigg, Burkert Pieske, Patrick Rossignol, Philippe Rouet, Jan A. Staessen, John G.F. Cleland, Stéphane Heymans, Faı̈ez Zannad
Topics & Concepts
SpironolactoneMineralocorticoid receptorMedicineInterquartile rangeInternal medicineHeart failureEplerenoneInflammationAdipokineEndocrinologyNatriuretic peptideAldosteroneInsulin resistanceInsulinHormonal Regulation and HypertensionHeart Failure Treatment and ManagementGDF15 and Related Biomarkers